Letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022 - Lilienfeld-Toal, Marie von; Agkatsev, S.; Glasmacher, A.; Reiß, P.; Sen, S.; Seltmann, A.; Wolf, S. (ESMO open, 2025)
Online veröffenticht: 11. April 2025